Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...

Biomedical researchers often ask what the best antibody is for their target. "The answer depends on a multitude of factors, from application and platform to the sample type being investigated," says ...

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization ...

Monoclonal antibodies (mAbs) bind to a variety of targets with high affinity and specificity, making them ideal therapeutics. However, traditional approaches to antibody screening workflows are labor ...

FARGO — Genovac is a biotechnology company that specializes in discovering antibodies that can be used to make vaccines and other drugs — including antibodies that are effective in neutralizing two ...

Antibody discovery research paves the way for new therapeutics. The search for the right antibody for a specific therapeutic application necessitates several iterations of antibody production and ...

Existing monoclonal antibody development technologies, such as hybridoma technology, suffer from a loss of diversity due to cell fusion efficiency, and phage display technology creates antibodies ...